NorthCrest Asset Manangement LLC Makes New $1.09 Million Investment in Astera Labs, Inc. $ALAB

NorthCrest Asset Manangement LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the fourth quarter, Holdings Channel reports. The institutional investor purchased 6,534 shares of the company’s stock, valued at approximately $1,092,000.

Several other large investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its stake in shares of Astera Labs by 29.6% in the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after purchasing an additional 2,751,747 shares during the last quarter. Amundi lifted its stake in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC bought a new stake in Astera Labs during the third quarter worth approximately $209,599,000. BNP Paribas Financial Markets boosted its holdings in Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after buying an additional 960,899 shares in the last quarter. Finally, 1832 Asset Management L.P. grew its position in Astera Labs by 151.4% in the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock worth $139,563,000 after buying an additional 929,600 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $123.87 on Tuesday. The firm has a 50 day simple moving average of $143.12 and a 200 day simple moving average of $165.60. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90. The company has a market cap of $21.08 billion, a PE ratio of 101.53, a price-to-earnings-growth ratio of 2.28 and a beta of 1.75.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same period in the previous year, the company posted $0.37 EPS. The company’s quarterly revenue was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Citigroup cut their price objective on Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, February 11th. Barclays set a $165.00 target price on Astera Labs in a report on Thursday, January 15th. Northland Securities upped their target price on Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a report on Tuesday, December 9th. Morgan Stanley reiterated an “overweight” rating and issued a $210.00 price target on shares of Astera Labs in a research report on Wednesday, December 3rd. Finally, Weiss Ratings cut Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Fifteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $202.22.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 94,971 shares of the firm’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the sale, the chief operating officer directly owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. This trade represents a 5.84% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Jitendra Mohan sold 157,500 shares of Astera Labs stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00. Following the transaction, the chief executive officer directly owned 4,531,732 shares in the company, valued at approximately $596,285,296.56. This trade represents a 3.36% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 384,292 shares of company stock valued at $48,724,919 in the last ninety days. Company insiders own 12.50% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.